Skip to main content
Aquestive Therapeutics, Inc. logo

Aquestive Therapeutics, Inc. — Investor Relations & Filings

Ticker · AQST ISIN · US03843E1047 US Manufacturing
Filings indexed 607 across all filing types
Latest filing 2026-04-24 Annual Report
Country US United States of America
Listing US AQST

About Aquestive Therapeutics, Inc.

https://aquestive.com/

Aquestive Therapeutics is a pharmaceutical company that develops and commercializes medicines using its proprietary PharmFilm® technology. This oral film drug delivery system provides a non-invasive and convenient alternative to conventional therapies, such as injections, by enabling the oral administration of complex molecules. The company's development pipeline is focused on addressing unmet medical needs in central nervous system (CNS) disorders and severe allergic reactions. Key product candidates include Anaphylm™, an epinephrine sublingual film for the emergency treatment of anaphylaxis, and Libervant®, a diazepam buccal film for the management of seizure clusters.

Recent filings

Filing Released Lang Actions
ARS - Aquestive Therapeutics, Inc. (0001398733) (Filer)
Annual Report
2026-04-24 English
8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)
Regulatory Filings
2026-03-30 English
8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)
Regulatory Filings
2026-03-20 English
8-K - AQUESTIVE THERAPEUTICS, INC. (0001398733) (Filer)
Regulatory Filings
2026-02-26 English
8-K Filing
Regulatory Filings
2026-02-02 English
S-8 Filing
Registration Form
2026-01-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.